Clinical trial
Phase I Study of Intravitreal Injections Versus Anterior Sub-Tenon Injections of Triamcinolone Acetonide Formulation for Macular Edema in Retinal Disorders
NCT00101764 is registered in ClinicalTrials.gov with National Eye Institute (NEI) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase I Study of Intravitreal Injections Versus Anterior Sub-Tenon Injections of Triamcinolone Acetonide Formulation for Macular Edema in Retinal Disorders
- Lead sponsor
- National Eye Institute (NEI)
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- January 5, 2005
- Completion date
- May 20, 2008
- Enrollment
- 120
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.